KPC Pharmaceuticals, Inc.
SHH: 600422.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Wei Yan
- Employees
- 5,275
- Headquarters
- Kunming, China
- IPO year
- 2000
- Market cap
- CN¥7.2B
- Website
- https://www.kpc.com.cn
Loading 600422…
Loading profile data…Frequently asked questions about 600422
What does KPC Pharmaceuticals, Inc. (600422.SS) do?
KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luota...
Where does 600422.SS trade?
KPC Pharmaceuticals, Inc. (600422.SS) trades on the Shanghai Stock Exchange.
What sector is 600422.SS in?
KPC Pharmaceuticals, Inc. (600422.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of KPC Pharmaceuticals, Inc.?
Wei Yan is the chief executive officer of KPC Pharmaceuticals, Inc. (600422.SS).
Where is KPC Pharmaceuticals, Inc. headquartered?
KPC Pharmaceuticals, Inc. is headquartered in China.
Does 600422.SS pay a dividend?
Yes — KPC Pharmaceuticals, Inc. (600422.SS) paid a trailing twelve-month dividend of CNY 0.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600422.SS go public?
KPC Pharmaceuticals, Inc. (600422.SS) completed its initial public offering in 2000.